$IZTC News
Last published 1y ago
- 1y agoIZTCMDBHRebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered EnzymesGlobeNewswireRebranding Invizyne Technologies, Inc to eXoZymes Inc.Changing NASDAQ ticker from IZTC to EXOZIntroducing but not trademarking "exozymes" as a new scientific nomenclature Monrovia, California, Feb. 12, 2025 (GLOBE
- 1y agoIZTCMDBHInvizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker SymbolGlobeNewswireMonrovia, CA, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ:IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially
- 1y agoIZTCMDBHInvizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel CapabilitiesGlobeNewswireMonrovia, CA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ:IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially
- 1y agoIZTCMDBHInvizyne Technologies Announces Closing of Initial Public OfferingGlobeNewswireMonrovia, CA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday
- 1y agoIZTCMDBHInvizyne's Nasdaq IPO Marks New Era of BiomanufacturingGlobeNewswireMonrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ:IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially
- 1y agoIZTCMDBHInvizyne Technologies Begins Trading on NASDAQGlobeNewswireMonrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday
- 2y agoIZTCMDBHInvizyne Technologies to Begin Trading on NASDAQ on November 13, 2024GlobeNewswireMonrovia, CA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday
- 2y agoIZTCMDBHInvizyne Technologies Announces Pricing of $15 Million Initial Public OfferingGlobeNewswireMonrovia, CA, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday